Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines.

van Montfoort N, Borst L, Korrer MJ, Sluijter M, Marijt KA, Santegoets SJ, van Ham VJ, Ehsan I, Charoentong P, André P, Wagtmann N, Welters MJP, Kim YJ, Piersma SJ, van der Burg SH, van Hall T.

Cell. 2018 Dec 13;175(7):1744-1755.e15. doi: 10.1016/j.cell.2018.10.028. Epub 2018 Nov 29.

PMID:
30503208
2.

Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells.

Ruggeri L, Urbani E, André P, Mancusi A, Tosti A, Topini F, Bléry M, Animobono L, Romagné F, Wagtmann N, Velardi A.

Haematologica. 2016 May;101(5):626-33. doi: 10.3324/haematol.2015.135301. Epub 2015 Dec 31.

3.

Cutting Edge: identification of neutrophil PGLYRP1 as a ligand for TREM-1.

Read CB, Kuijper JL, Hjorth SA, Heipel MD, Tang X, Fleetwood AJ, Dantzler JL, Grell SN, Kastrup J, Wang C, Brandt CS, Hansen AJ, Wagtmann NR, Xu W, Stennicke VW.

J Immunol. 2015 Feb 15;194(4):1417-21. doi: 10.4049/jimmunol.1402303. Epub 2015 Jan 16.

4.

Pillars article: Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity. 1996. 4: 77-85.

Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet JP, Long EO.

J Immunol. 2013 Oct 1;191(7):3491-9. No abstract available.

5.

Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-γ contributes to modulate immune responses.

Germain C, Meier A, Jensen T, Knapnougel P, Poupon G, Lazzari A, Neisig A, Håkansson K, Dong T, Wagtmann N, Galsgaard ED, Spee P, Braud VM.

J Biol Chem. 2011 Nov 4;286(44):37964-75. doi: 10.1074/jbc.M111.285312. Epub 2011 Sep 19.

6.

In vivo tumor cell rejection induced by NK cell inhibitory receptor blockade: maintained tolerance to normal cells even in the presence of IL-2.

Vahlne G, Lindholm K, Meier A, Wickström S, Lakshmikanth T, Brennan F, Wilken M, Nielsen R, Romagné F, Wagtmann NR, Kärre K, Johansson MH.

Eur J Immunol. 2010 Mar;40(3):813-23. doi: 10.1002/eji.200939755.

7.

NK cell activation by KIR-binding antibody 1-7F9 and response to HIV-infected autologous cells in viremic and controller HIV-infected patients.

Johansson SE, Hejdeman B, Hinkula J, Johansson MH, Romagné F, Wahren B, Wagtmann NR, Kärre K, Berg L.

Clin Immunol. 2010 Feb;134(2):158-68. doi: 10.1016/j.clim.2009.10.001. Epub 2009 Nov 1.

PMID:
19880352
8.

Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo.

Sola C, André P, Lemmers C, Fuseri N, Bonnafous C, Bléry M, Wagtmann NR, Romagné F, Vivier E, Ugolini S.

Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12879-84. doi: 10.1073/pnas.0901653106. Epub 2009 Jun 26.

9.

Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells.

Romagné F, André P, Spee P, Zahn S, Anfossi N, Gauthier L, Capanni M, Ruggeri L, Benson DM Jr, Blaser BW, Della Chiesa M, Moretta A, Vivier E, Caligiuri MA, Velardi A, Wagtmann N.

Blood. 2009 Sep 24;114(13):2667-77. doi: 10.1182/blood-2009-02-206532. Epub 2009 Jun 24.

10.

Essential role of platelet activation via protease activated receptor 4 in tissue factor-initiated inflammation.

Busso N, Chobaz-Péclat V, Hamilton J, Spee P, Wagtmann N, So A.

Arthritis Res Ther. 2008;10(2):R42. doi: 10.1186/ar2400. Epub 2008 Apr 15.

11.

Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV.

Bjelke JR, Christensen J, Nielsen PF, Branner S, Kanstrup AB, Wagtmann N, Rasmussen HB.

Biochem J. 2006 Jun 1;396(2):391-9.

12.

Circulating CD26 is negatively associated with inflammation in human and experimental arthritis.

Busso N, Wagtmann N, Herling C, Chobaz-Péclat V, Bischof-Delaloye A, So A, Grouzmann E.

Am J Pathol. 2005 Feb;166(2):433-42.

13.

Tyrosine 547 constitutes an essential part of the catalytic mechanism of dipeptidyl peptidase IV.

Bjelke JR, Christensen J, Branner S, Wagtmann N, Olsen C, Kanstrup AB, Rasmussen HB.

J Biol Chem. 2004 Aug 13;279(33):34691-7. Epub 2004 Jun 2.

14.

Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog.

Rasmussen HB, Branner S, Wiberg FC, Wagtmann N.

Nat Struct Biol. 2003 Jan;10(1):19-25.

PMID:
12483204
15.
16.

Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158).

Long EO, Barber DF, Burshtyn DN, Faure M, Peterson M, Rajagopalan S, Renard V, Sandusky M, Stebbins CC, Wagtmann N, Watzl C.

Immunol Rev. 2001 Jun;181:223-33. Review.

PMID:
11513144
17.

New nomenclature for MHC receptors.

André P, Biassoni R, Colonna M, Cosman D, Lanier LL, Long EO, Lopez-Botet M, Moretta A, Moretta L, Parham P, Trowsdale J, Vivier E, Wagtmann N, Wilson MJ.

Nat Immunol. 2001 Aug;2(8):661. No abstract available.

PMID:
11477395
18.

Natural killer cells and mast cells from gp49B null mutant mice are functional.

Rojo S, Stebbins CC, Peterson ME, Dombrowicz D, Wagtmann N, Long EO.

Mol Cell Biol. 2000 Oct;20(19):7178-82.

19.

Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26.

Marguet D, Baggio L, Kobayashi T, Bernard AM, Pierres M, Nielsen PF, Ribel U, Watanabe T, Drucker DJ, Wagtmann N.

Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6874-9.

20.

gp49: an Ig-like receptor with inhibitory properties on mast cells and natural killer cells.

Wagtmann N.

Curr Top Microbiol Immunol. 1999;244:107-13. Review. No abstract available.

PMID:
10453653
21.

Structure of a human natural killer cell inhibitory receptor.

Fan QR, Mosyak L, Garboczi DN, Winter CC, Wagtmann N, Long EO, Wiley DC.

Transplant Proc. 1999 Jun;31(4):1871-2. Review. No abstract available.

PMID:
10371978
22.

Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.

Winter CC, Gumperz JE, Parham P, Long EO, Wagtmann N.

J Immunol. 1998 Jul 15;161(2):571-7.

23.

Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors.

Fan QR, Mosyak L, Winter CC, Wagtmann N, Long EO, Wiley DC.

Nature. 1997 Sep 4;389(6646):96-100. Erratum in: Nature 1997 Nov 20;390(6657):315.

PMID:
9288975
24.

Negative signaling pathways of the killer cell inhibitory receptor and Fc gamma RIIb1 require distinct phosphatases.

Gupta N, Scharenberg AM, Burshtyn DN, Wagtmann N, Lioubin MN, Rohrschneider LR, Kinet JP, Long EO.

J Exp Med. 1997 Aug 4;186(3):473-8.

25.

A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors.

Wagtmann N, Rojo S, Eichler E, Mohrenweiser H, Long EO.

Curr Biol. 1997 Aug 1;7(8):615-8. No abstract available.

26.

Natural killer cell receptors.

Long EO, Wagtmann N.

Curr Opin Immunol. 1997 Jun;9(3):344-50. Review.

PMID:
9203417
27.

Killer cell inhibitory receptors: diversity, specificity, and function.

Long EO, Burshtyn DN, Clark WP, Peruzzi M, Rajagopalan S, Rojo S, Wagtmann N, Winter CC.

Immunol Rev. 1997 Feb;155:135-44. Review.

PMID:
9059889
28.
29.

Type I transmembrane receptor with inhibitory function in mouse mast cells and NK cells.

Rojo S, Burshtyn DN, Long EO, Wagtmann N.

J Immunol. 1997 Jan 1;158(1):9-12.

PMID:
8977169
30.
31.

Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule.

Fan QR, Garboczi DN, Winter CC, Wagtmann N, Long EO, Wiley DC.

Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7178-83.

32.

Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor.

Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet JP, Long EO.

Immunity. 1996 Jan;4(1):77-85.

33.

Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer.

Wagtmann N, Rajagopalan S, Winter CC, Peruzzi M, Long EO.

Immunity. 1995 Dec;3(6):801-9. No abstract available.

34.

The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells.

Rajagopalan S, Winter CC, Wagtmann N, Long EO.

J Immunol. 1995 Nov 1;155(9):4143-6.

PMID:
7594568
35.

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.

Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, Vitale M, Bottino C, Moretta L, Moretta A, Long EO.

Immunity. 1995 May;2(5):439-49.

Supplemental Content

Loading ...
Support Center